Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $12,143.34 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 22 shares of the business’s stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $551.97, for a total value of $12,143.34. Following the transaction, the senior vice president now directly owns 2,069 shares of the company’s stock, valued at $1,142,025.93. This represents a 1.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Mark Brosius also recently made the following trade(s):

• On Wednesday, May 14th, Mark Brosius sold 22 shares of Intuitive Surgical stock. The stock was sold at an average price of $563.00, for a total value of $12,386.00.
• On Friday, March 7th, Mark Brosius sold 489 shares of Intuitive Surgical stock. The stock was sold at an average price of $533.18, for a total value of $260,725.02.
• On Wednesday, March 5th, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $554.17, for a total value of $272,651.64.
• On Monday, March 3rd, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $573.78, for a total value of $282,299.76.

Intuitive Surgical Trading Down 1.0%

ISRG stock opened at $560.28 on Friday. Intuitive Surgical, Inc. has a 1-year low of $393.98 and a 1-year high of $616.00. The firm has a market cap of $200.81 billion, a P/E ratio of 87.41, a P/E/G ratio of 5.85 and a beta of 1.70. The business’s 50 day moving average is $503.82 and its 200-day moving average is $536.13.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same period in the prior year, the company earned $1.50 EPS. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on ISRG. Robert W. Baird cut their price objective on Intuitive Surgical from $600.00 to $575.00 and set an “outperform” rating for the company in a research report on Wednesday, April 23rd. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Royal Bank of Canada lowered their price target on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price target on Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Finally, JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $598.95.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently bought and sold shares of ISRG. Atala Financial Inc bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $25,000. Chilton Capital Management LLC grew its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 43 shares during the last quarter. Berbice Capital Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Parvin Asset Management LLC bought a new stake in Intuitive Surgical during the 4th quarter worth approximately $26,000. Finally, Global Financial Private Client LLC grew its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after acquiring an additional 38 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.